Comparing the clinical performance and cost efficacy of [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007 in the diagnosis of recurrent prostate cancer: a Markov chain decision analysis

PURPOSE: Amongst others, [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007 are available for the detection of recurrent prostate cancer (rPC). There are currently limited data comparing the performance of these two radioligands with respect to clinical outcomes or their cost efficacy, which this study aims to...

Descripción completa

Detalles Bibliográficos
Autores principales: Alberts, Ian, Mingels, Clemens, Zacho, Helle D., Lanz, Sabine, Schöder, Heiko, Rominger, Axel, Zwahlen, Marcel, Afshar-Oromieh, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525363/
https://www.ncbi.nlm.nih.gov/pubmed/34773473
http://dx.doi.org/10.1007/s00259-021-05620-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525363/
https://www.ncbi.nlm.nih.gov/pubmed/34773473
http://dx.doi.org/10.1007/s00259-021-05620-9

Ejemplares similares